GLAUKOS Corp (GKOS) stock

GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30239% above fair value

$237.60−4.88 (-2.01%)

Close on Oct 30, 2026Market cap $14.01BP/E –Yield –

Earnings

Glaukos's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Feb 16, 2027

Q4 FY2026 · estimated, after the close

Revenue, Q3 FY2026

$211.00M

+58.1% on a year earlier

non-GAAP diluted EPS, Q3 FY2026

$0.47

-$0.16 a year earlier

Latest guidance

Raised

Oct 28, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Glaukos's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q4 FY2026ended Dec 31, 2026	Feb 16, 2027Expected	–	–	–	–	–
Q3 FY2026ended Sep 30, 2026	Oct 28, 2026after the close	$211.00M	+58.1%	$0.03	$0.47	Release
Q2 FY2026ended Jun 30, 2026	Jul 29, 2026after the close	$185.60M	+49.6%	-$0.31	–	Release
Q1 FY2026ended Mar 31, 2026	Apr 29, 2026after the close	$150.60M	+41.1%	-$0.34	-$0.18	Release
Q4 FY2025ended Dec 31, 2025	Feb 17, 2026after the close	$143.10M	+35.6%	-$2.32	-$0.28	Release
Q3 FY2025ended Sep 30, 2025	Oct 29, 2025after the close	$133.50M	+38.1%	-$0.28	-$0.16	Release
Q2 FY2025ended Jun 30, 2025	Jul 30, 2025after the close	$124.10M	+29.7%	-$0.34	-$0.24	Release
Q1 FY2025ended Mar 31, 2025	Apr 30, 2025after the close	$106.70M	+24.6%	-$0.32	-$0.22	Release
Q4 FY2024ended Dec 31, 2024	Feb 20, 2025after the close	$105.50M	+28.0%	-$0.60	-$0.40	Release
Q3 FY2024ended Sep 30, 2024	Nov 4, 2024after the close	$96.70M	+24.0%	-$0.39	-$0.28	Release
Q2 FY2024ended Jun 30, 2024	Jul 31, 2024after the close	$95.70M	+19.0%	-$1.06	-$0.52	Release
Q1 FY2024ended Mar 31, 2024	May 1, 2024after the close	$85.60M	+15.8%	-$0.82	-$0.70	Release
Q4 FY2023ended Dec 31, 2023	Feb 21, 2024after the close	$82.40M	+15.7%	-$0.75	-$0.63	Release
Q3 FY2023ended Sep 30, 2023	Nov 1, 2023after the close	$78.00M	+9.4%	-$0.63	-$0.50	Release
Q2 FY2023ended Jun 30, 2023	Aug 2, 2023after the close	$80.40M	+10.6%	-$0.68	-$0.55	Release
Q1 FY2023ended Mar 31, 2023	May 3, 2023after the close	$73.90M	+9.2%	-$0.72	-$0.59	Release
Q4 FY2022ended Dec 31, 2022	Feb 22, 2023after the close	$71.20M	-2.7%	-$0.66	-$0.53	Release
Q3 FY2022ended Sep 30, 2022	Nov 2, 2022after the close	$71.30M	-4.6%	-$0.58	-$0.45	Release
Q2 FY2022ended Jun 30, 2022	Aug 3, 2022after the close	$72.70M	–	-$0.96	-$0.83	Release
Q1 FY2022ended Mar 31, 2022	May 4, 2022after the close	$67.70M	–	$0.11	-$0.38	Release
Q4 FY2021ended Dec 31, 2021	Feb 22, 2022after the close	$73.20M	–	-$0.47	-$0.31	Release
Q3 FY2021ended Sep 30, 2021	Nov 4, 2021after the close	$74.70M	–	$0.13	-$0.21	Release
Q2 FY2021ended Jun 30, 2021	Aug 5, 2021after the close	–	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	May 5, 2021after the close	–	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Feb 25, 2021after the close	–	–	–	–	Filing
Q3 FY2020ended Sep 30, 2020	Nov 5, 2020after the close	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Glaukos's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
net sales	FY2026	$775.00M – $785.00M	$600.00M – $620.00M	Raised	Oct 28, 2026
net sales	FY2026	$680.00M – $700.00M	$620.00M – $635.00M	Raised	Jul 29, 2026
net sales	FY2027	$1.00B	–	New	Oct 28, 2026

Guidance vs results

The last range Glaukos gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	Revenue	$490.00M – $495.00M	$507.40MΣ4Q	Above range

Guidance history

Every forecast Glaukos put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Oct 28, 2026	net sales	FY2026	$775.00M – $785.00M	Raised
Oct 28, 2026	net sales	FY2027	$1.00B	New
Jul 29, 2026	net sales	FY2026	$680.00M – $700.00M	Raised
Apr 29, 2026	net sales	FY2026	$620.00M – $635.00M	Raised
Feb 17, 2026	net sales	FY2026	$600.00M – $620.00M	New
Jan 13, 2026	net sales	FY2026	$600.00M – $620.00M	Reaffirmed
Oct 29, 2025	net sales	FY2025	$490.00M – $495.00M	New
Oct 29, 2025	preliminary net sales	FY2026	$600.00M – $620.00M	New
Jul 30, 2025	net sales	FY2025	$480.00M – $486.00M	Raised
Apr 30, 2025	net sales	FY2025	$475.00M – $485.00M	Reaffirmed
Feb 20, 2025	net sales	FY2025	$475.00M – $485.00M	New
Nov 4, 2024	net sales	FY2024	$377.00M – $379.00M	Raised
Jul 31, 2024	net sales	FY2024	$370.00M – $376.00M	Raised
May 1, 2024	net sales	FY2024	$357.00M – $365.00M	New
Feb 21, 2024	net sales	FY2024	$350.00M – $360.00M	Reaffirmed
Jan 9, 2024	net sales	FY2024	$350.00M – $360.00M	New
Nov 1, 2023	net sales	FY2023	$307.00M – $310.00M	Raised
Aug 2, 2023	net sales	FY2023	$304.00M – $308.00M	Raised
May 3, 2023	net sales	FY2023	$295.00M – $300.00M	Raised
Feb 22, 2023	net sales	FY2023	$290.00M – $295.00M	New
Nov 2, 2022	net sales	FY2022	$278.00M – $280.00M	Raised
Aug 3, 2022	net sales	FY2022	$275.00M – $280.00M	New
May 4, 2022	net sales	FY2022	$270.00M – $275.00M	Raised
Feb 22, 2022	net sales	FY2022	$265.00M – $275.00M	New
Nov 4, 2021	net sales	FY2021	$285.00M – $290.00M	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.